Ewa, LLC Novo Nordisk A S Transaction History

Ewa, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$122.71 - $146.91 $2,945 - $3,525	-24 Reduced 1.4%	1,692 $226 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $75,765 - $100,852	-742 Reduced 30.19%	1,716 $220 Million
Q4 2023 Feb 05, 2024	BUY	$87.78 - $105.45 $526 - $632	6 Added 0.24%	2,458 $279 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $222,984 - $489,272	2,452 New	2,452 $247 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $158,278 - $190,331	1,196 New	1,196 $205 Million

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

Stay updated on Ewa, LLC with notifications on news.